Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tyrosine kinase | 0.0108 | 0.2811 | 0.2804 |
Schistosoma mansoni | cyclin B | 0.002 | 0.0014 | 0.0005 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.002 | 0.0014 | 0.0014 |
Brugia malayi | Ryanodine Receptor TM 4-6 family protein | 0.0171 | 0.4791 | 0.4784 |
Loa Loa (eye worm) | AUR protein kinase | 0.0127 | 0.3414 | 0.3405 |
Entamoeba histolytica | protein kinase , putative | 0.0127 | 0.3414 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0127 | 0.3414 | 0.3405 |
Schistosoma mansoni | tyrosine kinase | 0.0336 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.0127 | 0.3414 | 0.3408 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0181 | 0.5112 | 0.5112 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0336 | 1 | 1 |
Echinococcus multilocularis | aurora kinase A | 0.0127 | 0.3414 | 0.3405 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0127 | 0.3414 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0178 | 0.5002 | 0.4997 |
Loa Loa (eye worm) | ryanodine receptor | 0.0064 | 0.1405 | 0.1393 |
Trichomonas vaginalis | AGC family protein kinase | 0.0127 | 0.3414 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0181 | 0.5112 | 0.5112 |
Echinococcus granulosus | cyclin B3 1 | 0.002 | 0.0014 | 0.0014 |
Trypanosoma brucei | aurora B kinase | 0.0127 | 0.3414 | 1 |
Schistosoma mansoni | cyclins | 0.002 | 0.0014 | 0.0005 |
Onchocerca volvulus | 0.002 | 0.0014 | 0.5 | |
Schistosoma mansoni | serine/threonine protein kinase | 0.0127 | 0.3414 | 0.3408 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0372 | 0.0358 |
Echinococcus granulosus | cyclins | 0.002 | 0.0014 | 0.0014 |
Echinococcus granulosus | insulin receptor | 0.0108 | 0.2811 | 0.2811 |
Toxoplasma gondii | aurora kinase | 0.0127 | 0.3414 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.28 | 0.279 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0021 | 0.0044 | 0.0034 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0127 | 0.3414 | 0.5 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.0062 | 0.1335 | 0.3883 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0127 | 0.3414 | 1 |
Echinococcus multilocularis | 0.0103 | 0.2655 | 0.2645 | |
Brugia malayi | serine/threonine protein kinase 6 | 0.0127 | 0.3414 | 0.3405 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.0044 | 0.003 |
Trichomonas vaginalis | AGC family protein kinase | 0.0127 | 0.3414 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0181 | 0.5112 | 0.5107 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0139 | 0.3763 | 0.3763 |
Trichomonas vaginalis | AGC family protein kinase | 0.0127 | 0.3414 | 1 |
Brugia malayi | serine/threonine kinase 12 | 0.0127 | 0.3414 | 0.3405 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0127 | 0.3414 | 1 |
Schistosoma mansoni | cyclin B3 | 0.002 | 0.0014 | 0.0005 |
Schistosoma mansoni | tyrosine kinase | 0.0178 | 0.5002 | 0.4997 |
Brugia malayi | Protein kinase domain containing protein | 0.0108 | 0.2811 | 0.2801 |
Loa Loa (eye worm) | AUR protein kinase | 0.0127 | 0.3414 | 0.3405 |
Trichomonas vaginalis | AGC family protein kinase | 0.0127 | 0.3414 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0336 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.3941 | 0.3933 |
Leishmania major | protein kinase, putative | 0.0127 | 0.3414 | 1 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.0062 | 0.1335 | 0.3883 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0336 | 1 | 1 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0127 | 0.3414 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0127 | 0.3414 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.3941 | 0.3933 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.3941 | 0.3933 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0127 | 0.3414 | 0.3414 |
Echinococcus granulosus | cyclins | 0.002 | 0.0014 | 0.0014 |
Schistosoma mansoni | ryanodine receptor related | 0.0171 | 0.4791 | 0.4786 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0108 | 0.2811 | 0.2801 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0127 | 0.3414 | 1 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0108 | 0.2811 | 0.2811 |
Echinococcus multilocularis | insulin receptor | 0.0108 | 0.2811 | 0.2801 |
Schistosoma mansoni | tyrosine kinase | 0.0178 | 0.5002 | 0.4997 |
Leishmania major | hypothetical protein, conserved | 0.0042 | 0.071 | 0.2048 |
Loa Loa (eye worm) | AUR protein kinase | 0.0127 | 0.3414 | 0.3405 |
Brugia malayi | cation channel family protein | 0.0073 | 0.1697 | 0.1685 |
Echinococcus granulosus | aurora kinase A | 0.0127 | 0.3414 | 0.3414 |
Echinococcus granulosus | cyclins | 0.002 | 0.0014 | 0.0014 |
Schistosoma mansoni | hypothetical protein | 0.0042 | 0.0719 | 0.071 |
Echinococcus granulosus | cyclin b3 | 0.002 | 0.0014 | 0.0014 |
Echinococcus granulosus | cyclin B | 0.002 | 0.0014 | 0.0014 |
Giardia lamblia | Aurora kinase | 0.0127 | 0.3414 | 1 |
Echinococcus granulosus | cyclins | 0.002 | 0.0014 | 0.0014 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0108 | 0.2811 | 0.2801 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0052 | 0.1038 | 0.103 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0021 | 0.0044 | 0.003 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0127 | 0.3414 | 0.3405 |
Loa Loa (eye worm) | ryanodine receptor | 0.004 | 0.0661 | 0.0648 |
Schistosoma mansoni | tyrosine kinase | 0.0108 | 0.2811 | 0.2804 |
Entamoeba histolytica | protein kinase, putative | 0.0127 | 0.3414 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0044 | 0.003 |
Echinococcus granulosus | cyclins | 0.002 | 0.0014 | 0.0014 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0414 | 0.0401 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0108 | 0.28 | 0.28 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0127 | 0.3414 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0181 | 0.5112 | 0.5107 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0108 | 0.28 | 0.279 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0139 | 0.3763 | 0.3754 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0181 | 0.5112 | 0.5105 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.8184 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.